Covered recipient · General Payments record
PATRICIA M MCCARTHY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$551.00
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $191.23 | 8 |
| Education | $94.62 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $94.62 | 1 |
| Mylan Specialty L.P. | $57.73 | 2 |
| United Therapeutics Corporation | $30.24 | 1 |
| Actelion Pharmaceuticals US, Inc. | $28.39 | 1 |
| GlaxoSmithKline, LLC. | $23.00 | 1 |
| Acerta Pharma LLC | $19.73 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.21 | 1 |
| Insmed, Inc. | $13.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $28.39 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078894599 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.73 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104650769 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.21 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118036155 | CMS |
| GlaxoSmithKline, LLC. | $23.00 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116649733 | CMS |
| Insmed, Inc. | $13.93 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089579764 | CMS |
| Mylan Specialty L.P. | $26.48 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147290582 | CMS |
| Mylan Specialty L.P. | $31.25 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147316854 | CMS |
| Regeneron Healthcare Solutions, Inc. | $94.62 | 02/23/2024 | Education | Undisputed | 01/23/2026 | 1114339862 | CMS |
| United Therapeutics Corporation | $30.24 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149455736 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.